Please login or signup to unlock the videos.Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.
In this discussion-based symposium, Professor Carel Le Roux, Professor Sadaf Farooqi and Dr Elizabeth Forsythe answer the following questions:
- - Hyperphagia – what is it, and what does insatiable hunger mean?
- - How can genetic impairments in the MC4R pathway lead to hyperphagia and early-onset, severe obesity?
- - What is the real-life burden of hyperphagia on patients with Bardet-Biedl syndrome?
- - Why are early diagnosis, referral and genetic testing crucial to support patient outcomes?
- - What does good MDT care look like for patients with MC4R pathway diseases?
